These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5755471)

  • 1. [Anabolic hormones in chronic hepatitis. Oral therapy with 1 alpha, 17 alpha-bis(acetylthio)-17 alpha-methyltestosterone].
    Pezold FA
    Munch Med Wochenschr; 1968 Nov; 110(45):2663-8. PubMed ID: 5755471
    [No Abstract]   [Full Text] [Related]  

  • 2. [Azathioprine in active chronic hepatitis].
    Danieli G; Dalmonte PR; Montroni M
    Minerva Med; 1970 Jul; 61(55):3032-9. PubMed ID: 4193544
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic hepatitis.
    Williams R
    Trans Med Soc Lond; 1968; 84():173-81. PubMed ID: 5708151
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of the use of a chronopluricorticoid in the therapy of active chronic hepatitis].
    Mauro R; Calatola P; D'Arco AM; Lettieri A; Maiorino A; Santoro A
    Clin Ter; 1979 Oct; 91(1):19-40. PubMed ID: 397870
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of inflammatory liver diseases with 6-mercaptopurine (6-MP)].
    Weinreich J
    Acta Hepatosplenol; 1967; 14(4):189-98. PubMed ID: 5589685
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of some metabolic effects of an orally active steroidyl-17-beta-enolether (quinbolone) with anabolic action].
    Balestreri R; Jacopino GE; Pompei A
    Arch Maragliano Patol Clin; 1966; 22(4):369-85. PubMed ID: 6014627
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical, biological and morphological comparisons in study of the evolutive possibilities of chronic hepatitis].
    Fodor O; Ban A; Nicoară G; Fodor I
    Med Interna (Bucur); 1972 Jun; 24(6):687-96. PubMed ID: 5069808
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in glucose tolerance after interferon-alpha therapy in patients with chronic hepatitis C.
    Tanaka H; Shiota G; Kawasaki H
    J Med; 1997; 28(5-6):335-46. PubMed ID: 9604792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of liver function during administration of nifenazone in rheumatic disease on the basis of serum protein studies and enzyme tests.
    Gola A; Galazka Z; Szczeklik A
    Mater Med Pol; 1972; 4(2):66-70. PubMed ID: 4270064
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic liver disease exacerbated during alpha-interferon treatment].
    Rodríguez Moreno F; González Reimers CE; Santolaria Fernández F; García Castro C; Martínez Riera A; Batista López N
    Rev Esp Enferm Dig; 1995 Nov; 87(11):825-7. PubMed ID: 8534541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intelligent use of liver function tests.
    Curtis SJ
    J Iowa Med Soc; 1972 Feb; 62(2):82-4 passim. PubMed ID: 5008704
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic hepatitis: nosographic, diagnostic and prognostic aspects].
    Hoancă O; Gheorghescu B; Russu M; Aposteanu G; Runcan V
    Med Interna (Bucur); 1972 Jun; 24(6):677-86. PubMed ID: 5069807
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of progressive chronic hepatitis with intravenous administrations of colloidal iron].
    Fleischer J; Morgenstern D
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):29-30. PubMed ID: 5501422
    [No Abstract]   [Full Text] [Related]  

  • 14. [Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid].
    Mörk H; al-Taie O; Klinge O; Scheurlen M
    Z Gastroenterol; 1997 Dec; 35(12):1087-91. PubMed ID: 9487641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha therapy alters glucose metabolism in patients with chronic hepatitis B.
    Tanaka H; Shiota G; Kawasaki H
    J Med; 1997; 28(5-6):325-34. PubMed ID: 9604791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dysfunctional correlations in chronic hepatitis. Significance of lesional "asynchronism and asymmetry" and of "discordances" in hepatic functional-biochemical tests].
    Fodor O; Barbarino F
    Med Interna (Bucur); 1971 May; 23(5):545-63. PubMed ID: 4105453
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis of liver diseases. General introduction to the problem and its clinical aspects].
    Caniggia A
    Quad Sclavo Diagn; 1971 Dec; 7(4):1020-1. PubMed ID: 5161734
    [No Abstract]   [Full Text] [Related]  

  • 18. [Some liver function tests performed on patients suffering from cerebrovascular accidents].
    Kawiak W; Dudkowska A
    Ann Univ Mariae Curie Sklodowska Med; 1967; 22():79-84. PubMed ID: 5617879
    [No Abstract]   [Full Text] [Related]  

  • 19. [Early diagnosis of chronic hepatitis].
    Novikov VS; Mironenko VA; Shusterov MI; Lezhenina NP
    Voen Med Zh; 1984 Apr; (4):36-8. PubMed ID: 6730371
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical applications of anabolic steroids and their mechanism of action--effect on liver function, especially on the BSP test].
    Yoshitoshi Y; Oda T; Suzuki H; Naito C; Yamanaka M
    Saishin Igaku; 1966 May; 21(5):1059-71. PubMed ID: 5966054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.